Caffeine Intake and Atrial Fibrillation Incidence: Dose Response Meta-analysis of Prospective Cohort Studies

Canadian Journal of Cardiology

Volumn 30, Issue 4, 2014, Pages 448-454

  Cheng, Min ^a   Hu, Zunsong ^a   Lu, Xiangfeng ^a   Huang, Jianfeng ^a   Gu, Dongfeng ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE;

CARDIOVASCULAR RISK; COFFEE; COHORT ANALYSIS; DISEASE ASSOCIATION; DOSE RESPONSE; HAZARD RATIO; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; LONG TERM EXPOSURE; META ANALYSIS; NONLINEAR SYSTEM; REVIEW;

ATRIAL FIBRILLATION; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INCIDENCE; PROSPECTIVE STUDIES;

EID: 84897874944     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2013.12.026     Document Type: Review

References (35)

1. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm A.J., et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010, 31:2369-2429. [erratum in 2011;32:1172].
2. Fuster V., Ryden L.E., Cannom D.S., et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011, 123:e269-e367.
3. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001, 285:2370-2375.
4. Freedman N.D., Park Y., Abnet C.C., Hollenbeck A.R., Sinha R. Association of coffee drinking with total and cause-specific mortality. NEngl J Med 2012, 366:1891-1904.
5. Mesas A.E., Leon-Munoz L.M., Rodriguez-Artalejo F., Lopez-Garcia E. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr 2011, 94:1113-1126.
6. Mostofsky E., Rice M.S., Levitan E.B., Mittleman M.A. Habitual coffee consumption and risk of heart failure: a dose-response meta-analysis. Circ Heart Fail 2012, 5:401-405.
7. O'Keefe J.H., Bhatti S.K., Patil H.R., et al. Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. JAm Coll Cardiol 2013, 62:1043-1051.
8. Malerba S., Turati F., Galeone C., et al. Ameta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases. Eur J Epidemiol 2013, 28:527-539.
9. Chelsky L.B., Cutler J.E., Griffith K., et al. Caffeine and ventricular arrhythmias. An electrophysiological approach. JAMA 1990, 264:2236-2240.
10. Graboys T.B., Blatt C.M., Lown B. The effect of caffeine on ventricular ectopic activity in patients with malignant ventricular arrhythmia. Arch Intern Med 1989, 149:637-639.
11. Caldeira D., Martins C., Alves L.B., et al. Caffeine does not increase the risk of atrial fibrillation: a systematic review and meta-analysis of observational studies. Heart 2013, 99:1383-1389.
12. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
13. Greenland S., Longnecker M.P. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992, 135:1301-1309.
14. Orsini N., Li R., Wolk A., Khudyakov P., Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 2012, 175:66-73.
15. McCusker R.R., Goldberger B.A., Cone E.J. Caffeine content of specialty coffees. JAnal Toxicol 2003, 27:520-522.
16. Frost L., Vestergaard P. Caffeine and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Clin Nutr 2005, 81:578-582.
17. Conen D., Chiuve S.E., Everett B.M., et al. Caffeine consumption and incident atrial fibrillation in women. Am J Clin Nutr 2010, 92:509-514.
18. Klatsky A.L., Hasan A.S., Armstrong M.A., Udaltsova N., Morton C. Coffee, caffeine, and risk of hospitalization for arrhythmias. Perm J 2011, 15:19-25.
19. Shen J., Johnson V.M., Sullivan L.M., et al. Dietary factors and incident atrial fibrillation: the Framingham Heart Study. Am J Clin Nutr 2011, 93:261-266.
20. Mukamal K.J., Hallqvist J., Hammar N., et al. Coffee consumption and mortality after acute myocardial infarction: the Stockholm Heart Epidemiology Program. Am Heart J 2009, 157:495-501.
21. Wilhelmsen L., Rosengren A., Lappas G. Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors. JIntern Med 2001, 250:382-389.
22. Klatsky A.L., Koplik S., Kipp H., Friedman G.D. The confounded relation of coffee drinking to coronary artery disease. Am J Cardiol 2008, 101:825-827.
23. Heeringa J., Kors J.A., Hofman A., van Rooij F.J., Witteman J.C. Cigarette smoking and risk of atrial fibrillation: the Rotterdam Study. Am Heart J 2008, 156:1163-1169.
24. Caron M.F., Song J., Ammar R., Kluger J., White C.M. An evaluation of the change in electrocardiographic P-wave variables after acute caffeine ingestion in normal volunteers. JClin Pharm Ther 2001, 26:145-148.
25. Ammar R., Song J.C., Kluger J., White C.M. Evaluation of electrocardiographic and hemodynamic effects of caffeine with acute dosing in healthy volunteers. Pharmacotherapy 2001, 21:437-442.
26. Myers M.G., Harris L., Leenen F.H., Grant D.M. Caffeine as a possible cause of ventricular arrhythmias during the healing phase of acute myocardial infarction. Am J Cardiol 1987, 59:1024-1028.
27. Corti R., Binggeli C., Sudano I., et al. Coffee acutely increases sympathetic nerve activity and blood pressure independently of caffeine content: role of habitual versus nonhabitual drinking. Circulation 2002, 106:2935-2940.
28. Molloy J.W., Calcagno C.J., Williams C.D., et al. Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology 2012, 55:429-436.
29. Anty R., Marjoux S., Iannelli A., et al. Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery. JHepatol 2012, 57:1090-1096.
30. Arauz J., Moreno M.G., Cortes-Reynosa P., Salazar E.P., Muriel P. Coffee attenuates fibrosis by decreasing the expression of TGF-beta and CTGF in a murine model of liver damage. JAppl Toxicol 2013, 33:970-979.
31. Arauz J., Zarco N., Segovia J., et al. Caffeine prevents experimental liver fibrosis by blocking the expression of TGF-β. Eur J Gastroenterol Hepatol 2014, 26:164-173.
32. Gressner O.A., Lahme B., Rehbein K., et al. Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways. JHepatol 2008, 49:758-767.
33. Swartz M.F., Fink G.W., Sarwar M.F., et al. Elevated pre-operative serum peptides for collagen I and III synthesis result in post-surgical atrial fibrillation. JAm Coll Cardiol 2012, 60:1799-1806.
34. den Uijl D.W., Delgado V., Bertini M., et al. Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation. Heart 2011, 97:1847-1851.
35. Burstein B., Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. JAm Coll Cardiol 2008, 51:802-809.